Recap: BioCryst Pharmaceuticals Q4 Earnings

BioCryst Pharmaceuticals BCRX reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioCryst Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.4 versus an estimate of $-0.3.

Revenue was up $43.14 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 6.37% drop in the share price the next day.

Here's a look at BioCryst Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.